Submitted by Anonymous (not verified) on 18 April 2024 - 14:45
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 30, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 30, Status: Authorised